Cover Image
市場調查報告書

TVAX Biomedical, Inc. - 產品平台分析

TVAX Biomedical, Inc. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 251729
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
TVAX Biomedical, Inc. - 產品平台分析 TVAX Biomedical, Inc. - Product Pipeline Review - 2016
出版日期: 2016年03月30日 內容資訊: 英文 32 Pages
簡介

TVAX Biomedical, Inc.是總公司設立於美國的生物科技企業,正在從事癌症治療的免疫細胞療法藥的開發。該公司藉由細胞毒性T細胞和癌症疫苗的聯合治療取得專利,正在開發治療腦瘤,腎臟癌用之開發平台的TVAX產品。

本報告提供TVAX Biomedical, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

目錄

TVAX Biomedical, Inc. 的基本資料

  • TVAX Biomedical, Inc. 概要
  • 主要資訊
  • 企業資料

TVAX Biomedical, Inc. :R&D概要

  • 主要的治療範圍

TVAX Biomedical, Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

TVAX Biomedical, Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
    • 第Ⅰ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

TVAX Biomedical, Inc. :藥物簡介

  • TVI-Brain-1
  • TVI-Kidney-1
  • TVI-Breast-1
  • TVI-Colon-1
  • TVI-Leukemia-1
  • TVI-Lung-1
  • TVI-Melanoma-1
  • TVI-Ovary-1
  • TVI-Pancreas-1
  • TVI-Prostate-1
  • TVI-Hepatitis-1
  • TVI-HIV-1
  • TVI-Tuberculosis-1

TVAX Biomedical, Inc. :開發平台分析

  • 標的別
  • 各分子類型

TVAX Biomedical, Inc. :最新的開發平台資訊

TVAX Biomedical, Inc. :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08011CDB

Summary

Global Markets Direct's, 'TVAX Biomedical, Inc. - Product Pipeline Review - 2016', provides an overview of the TVAX Biomedical, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by TVAX Biomedical, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of TVAX Biomedical, Inc.
  • The report provides overview of TVAX Biomedical, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses TVAX Biomedical, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features TVAX Biomedical, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate TVAX Biomedical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for TVAX Biomedical, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding TVAX Biomedical, Inc.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • TVAX Biomedical, Inc. Snapshot
    • TVAX Biomedical, Inc. Overview
    • Key Information
    • Key Facts
  • TVAX Biomedical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • TVAX Biomedical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • TVAX Biomedical, Inc. - Pipeline Products Glance
    • TVAX Biomedical, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • TVAX Biomedical, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • TVAX Biomedical, Inc. - Drug Profiles
    • TVI-Brain-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Kidney-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Breast-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Colon-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Leukemia-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Lung-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Melanoma-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Ovary-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Pancreas-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Prostate-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Hepatitis-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-HIV-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TVI-Tuberculosis-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • TVAX Biomedical, Inc. - Pipeline Analysis
    • TVAX Biomedical, Inc. - Pipeline Products by Route of Administration
    • TVAX Biomedical, Inc. - Pipeline Products by Molecule Type
  • TVAX Biomedical, Inc. - Recent Pipeline Updates
  • TVAX Biomedical, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • TVAX Biomedical, Inc., Key Information
  • TVAX Biomedical, Inc., Key Facts
  • TVAX Biomedical, Inc. - Pipeline by Indication, 2016
  • TVAX Biomedical, Inc. - Pipeline by Stage of Development, 2016
  • TVAX Biomedical, Inc. - Monotherapy Products in Pipeline, 2016
  • TVAX Biomedical, Inc. - Phase II, 2016
  • TVAX Biomedical, Inc. - Phase I, 2016
  • TVAX Biomedical, Inc. - Preclinical, 2016
  • TVAX Biomedical, Inc. - Pipeline by Route of Administration, 2016
  • TVAX Biomedical, Inc. - Pipeline by Molecule Type, 2016
  • TVAX Biomedical, Inc. - Recent Pipeline Updates, 2016

List of Figures

  • TVAX Biomedical, Inc. - Pipeline by Top 10 Indication, 2016
  • TVAX Biomedical, Inc. - Pipeline by Stage of Development, 2016
  • TVAX Biomedical, Inc. - Monotherapy Products in Pipeline, 2016
  • TVAX Biomedical, Inc. - Pipeline by Route of Administration, 2016
  • TVAX Biomedical, Inc. - Pipeline by Molecule Type, 2016
Back to Top